PEXA GROUP LIMITED (PXA)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

PXA

PXA - PEXA GROUP LIMITED

FNArena Sector : Real Estate
Year End: June
GICS Industry Group : Real Estate
Debt/EBITDA: 3.55
Index: ASX200 | ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$11.25

20 Feb
2025

-0.150

OPEN

$11.25

-1.32%

HIGH

$11.47

823,636

LOW

$11.19

TARGET
$15.083 34.1% upside
OTHER COMPANIES IN THE SAME SECTOR
APZ . DGH . DHG . HMC . REA . RMY . UBN .
FNARENA'S MARKET CONSENSUS FORECASTS
PXA: 1
Title FY23
Actual
FY24
Actual
FY25
Forecast
FY26
Forecast
EPS (cps) xxx - 10.2 20.6 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 55.2 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx-10.2
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx340.1 M
Book Value Per Share xxxxxxxxxxxxxxx691.6
Net Operating Cash Flow xxxxxxxxxxxxxxx109.9 M
Net Profit Margin xxxxxxxxxxxxxxx-5.30 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx-1.46 %
Return on Invested Capital xxxxxxxxxxxxxxx-1.15 %
Return on Assets xxxxxxxxxxxxxxx-0.97 %
Return on Equity xxxxxxxxxxxxxxx-1.46 %
Return on Total Capital xxxxxxxxxxxxxxx0.96 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx108.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx3 M
Long Term Debt xxxxxxxxxxxxxxx372 M
Total Debt xxxxxxxxxxxxxxx375 M
Goodwill - Gross xxxxxxxxxxxxxxx749 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx90 M
Price To Book Value xxxxxxxxxxxxxxx1.99

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx68.8 M
Capex % of Sales xxxxxxxxxxxxxxx20.25 %
Cost of Goods Sold xxxxxxxxxxxxxxx141 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx184 M
Research & Development xxxxxxxxxxxxxxx27 M
Investments - Total xxxxxxxxxxxxxxx33 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

3
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

20/01/2025

1

Upgrade to Add from Hold

$14.61

29.87%

Morgans marks-to-market earnings forecasts for insurance and diversified financials, considering market performance, the weaker AUD, and higher bond yields in Australia, the US, and Great Britain.

The broker upgrades Pexa Group to Add from Hold with a $14.61 target price.

There are no changes to Morgans' earnings forecasts for the group.

FORECAST
Morgans forecasts a full year FY25 dividend of 0.00 cents and EPS of 21.40 cents.
Morgans forecasts a full year FY26 dividend of 0.00 cents and EPS of 40.60 cents.

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Goldman Sachs

14/11/2024

1

Buy

$16.00

42.22%

Goldman Sachs notes Pexa Group's 1Q25 trading update showed strong transfer growth, up 14%, indicating a recovery in the property market and setting the stage for revenue to hit the high end of FY25 guidance.

The broker expects FY25 revenue growth of 13-19%, with an operating earnings (EBITDA) margin above 34%, although some challenges persist due to delayed testing for PEXA Pay in the UK, now anticipated for 3Q25.

The shift in PEXA Pay timelines impacts the broader UK roll-out, yet lender engagement remains positive, supporting the broker’s optimism for future adoption.

Goldman Sachs lowers its target price to $16.00 from $16.20 and maintains a Buy rating.

FORECAST
Goldman Sachs forecasts a full year FY25 dividend of 0.00 cents and EPS of 9.00 cents.
Goldman Sachs forecasts a full year FY26 dividend of 0.00 cents and EPS of 26.00 cents.

PXA STOCK CHART